Introduction
The problem of stroke In the next year about 100,000 people in the United Kingdom will have a definite first stroke and many others will have symptoms suggestive of stroke. Of the definite strokes about 20,000 will die and about 30,000 survivors will be seriously disabled.' After recovery from stroke the survivors will be at risk of recurrence and other vascular events such as myocardial infarction and vascular death. The economic burden of stroke is large, approximately 5% of the total National Health Service budget.2 There will be additional direct costs to the Social Services and indirect costs to the community from the lost income of unpaid carers.
About 85% of strokes are due to cerebral infarction (caused by occlusion of extracranial or intracranial cerebral vessels), 10% are due to primary intracerebral haemorrhage and 5% are due to subarachnoid haemorrhage.3 Stroke is a heterogeneous disease with a wide variety of clinical presentations, each associated with differing prognosis. The clinical management of patients in the acute phase of stroke remains controversial. Imaging and cerebral function techniques have advanced enormously, yet the most appropriate scheme of investigation and the most effective treatment ofa patient with suspected acute stroke is not clear, a contrast to the investigation and management of other occlusive vascular diseases such as myocardial infarction. This review will concentrate on strategies for the investigation of all forms of suspected stroke with the exception of the clinically distinct syndrome of subarachnoid haemorrhage, which has recently been reviewed very well by Vermeulen.4 We will also briefly review the general principles of the assessment of diagnostic tests and then the value of specific tests in the assessment of suspected stroke.
Why investigate a stroke?
'Errors in judgment must occur in the practice ofan art which consists largely in balancing probabilities.' Sir William Osler.
The reasons for investigating an individual patient presenting with suspected acute stroke are varied. Decision analysis with formal modelling may provide a better way of selecting appropriate tests, but is still a relatively crude indicator of the most cost-effective form of investigation. Algorithm flowcharts can provide a rigid protocol to follow, but may need to be altered as technology advances, or to suit different institutions (with differing patterns of disease presenting and differing investigational facilities), or to suit the views of different physicians (depending on their view of what constitutes the best treatment). Nonetheless, a systematic approach should ensure that the investigation of patients with stroke becomes more rational, more cost-effective and less risky.
General aims ofinvestigation (a) Confirm the diagnosis of stroke The main differential diagnoses for stroke are listed in Table  I . The majority of these can be excluded by careful attention to establishing the history. If there is a clear history of sudden onset, non-stroke lesions are very unlikely. If there is doubt about speed of onset or progression or if the patient is confused, dysphasic or comatose, a telephone call (cost, a few pence) to talk to a witness or member of the close family may be the most cost-effective investigation and is certainly easier to obtain than a computed tomographic (CT) scan (cost £50-80). Surveys of admissions with suspected stroke to stroke units and neurological wards reveal a 5-13% incidence of 'non-stroke' lesions, largely unrecognized seizures or confusional states.5-' In a communitybased sample of patients the proportion of 'nonstroke' lesions will be lower 1.5%,3 reflecting admission bias; a patient with an atypical clinical picture associated with a 'non-stroke' lesion is more likely to be admitted to hospital.
(b) Clarify the pathology The distinction between cerebral infarction and primary intracerebral haemorrhage may be important ifanti-haemostatic treatment is contemplated. A scoring system based on clinical features enables the calculation of a probability ratio for cerebral haemorrhage,7 but this may incorrectly classify some small deep haemorrhages as infarcts. The mechanism of infarction may be identified; for example differentiating between arterial or venous occlusion (e) As a guide to treatment (i) Acute phase of stroke. For the majority of strokes there is no currently available, widely practicable treatment which has been demonstrated to improve survival or reduce the functional handicap after stroke. Many clinicians feel that there is little point in extensive investigation of patients soon after stroke onset if no effective treatment is available. This rather nihilistic view of stroke ignores the small proportion ofpatients who have a non-stroke lesion or a treatable type of stroke (Tables I and II) . If effective treatments for stroke become available it will be important to identify those who may benefit. For example, if early thrombolysis and arterial recanalization is shown to improve outcome it will become important to identify patients with a cerebral infarction, persisting occlusion of a major cerebral artery, and with potentially viable ischaemic tissue before treatment is started.
(ii) Long-term secondary prevention. If long-term treatment with antiplatelet or anticoagulants is planned, or if the patient is at high risk ofdeep vein thrombosis (and may require anticoagulation) it is necessary to exclude primary intracerebral haemorrhage before starting treatment.
(f) To make or to save money Investigating patients purely for profit is not a practice which most clinicians would readily admit to, but may be a powerful determinant ofmedical practice in some parts of the world. More relevant to the National Health Service, an investigation may, by avoiding a disabling mis-diagnosis or by identifying appropri- 
Evaluation of an investigative test
The precision with which an individual test can identify the presence or absence of disease can be expressed in a number of measures which are assessed in a formal study comparing the tests performance with a 'gold standard' test. For example, Doppler ultrasonography of the carotid arteries can be assessed by comparison with the 'gold standard' of intra-arterial angiography to determine sensitivity (the probability of detecting disease when it is present) and specificity (the probability of excluding disease when it is absent) for the detection of carotid stenosis. The positive predictive value of a test is the proportion of patients with a positive test result who have the disease and the negative predictive value is the proportion of patients with negative test results who do not have the disease. Sensitivity and specificity do not change with alterations in the prevalence of disease in the population under test. However, the positive predictive value is greatly Basic investigations applicable to every patient These are listed in Table IV Full blood count may point to rare causes of stroke such as blood dyscrasia, polycythaemia, thrombocytopaenia, thrombocytosis or infection.
ESR-its role is to screen for vasculitis, bacterial endocarditis or hyperviscosity as the cause of stroke.
Biochemical screen may provide evidence that the neurological deficit is due to metabolic disturbance In the future, some assessment of the patency of intra-and extra-cranial arteries may be required before treatment with thrombolytic therapy in acute ischaemic stroke. In a recent series Fieschi et al.34 demonstrated complete occlusion of the apropriate cerebral artery in 76% of patients with acute ischaemic stroke who underwent angiography within 6 hours of stroke onset. Such patients may be suitable for entry in randomized trials of thrombolytic therapy, although patients who might have most to gain would be those with a viable ischaemic 'penumbra' distal to the site of vascular occlusion. The assessment of the site and size of any penumbra is not feasible with current techniques. There were 2 cases (2.5%, 95% confidence interval 0.3-8.8%) ofclinical deterioration following angiography in this series;34 angiography in the acute phase therefore carries a significant risk.
Angiography may be indicated in patients who have made a good recovery from a mild ischaemic stroke, ifcarotid endarterectomy to prevent further stroke is being considered. In this situation, the risk ofpermanent neurological deficit as a complication of angiography is approximately 1%.61 This complication rate should be added to the 3-4% risk of disabling stroke/death associated with carotid surgery. Intravenous digital subtraction angiography fails to provide the anatomical definition required to plan carotid surgery and carries a 17% risk of systemic complications associated with the administration of large volumes of contrast material.62 As a screening test to select patients for intra-arterial angiography, duplex ultrasound examination of the carotid extracranial circulation offers a sensitivity and specificity comparable to that of intravenous digital subtraction angiography without the potential complications.63
New investigations limited to research at present but which may be used in routine clinical application in the future
(A) Transcranial Doppler ultrasonography (TCD)
This technique uses a low-frequency pulsed ultrasound beam and a detector which can record flow velocities at selected distances from the probe. The beam can be directed through an 'orbital' window to record information about the carotid siphon, a 'temporal' window to record velocities in the middle, posterior and anterior cerebral arteries, and the foramen magnum to record velocities in the vertebrobasilar system. Absolute velocity measurements do not correlate well with cerebral blood flow for a number of reasons but comparison of velocities with the contralateral hemisphere and assessment of collateral and retrograde flow gives information about proximal occlusion ofthe major cerebral vessels. In 5-15% of patients it is not possible to make satisfactory recordings through the temporal window as a result of the thickness of the vault or anatomical variations in the blood vessels.' Each examination can take a long time (up to 1 hour per examination) and the diagnostic accuracy is highly dependent on the experience of the operator. In future it may provide an alternative to angiography in the early diagnosis and follow-up of intracranial arterial occlusion in acute ischaemic stroke. Preliminary studies suggest a high sensitivity and specificity for the diagnosis of proximal middle cerebral artery occlusion.65 (B) Nuclear magnetic resonance imaging (NMR) This non-invasive technique records the highfrequency radio waves emitted by protons as they are manipulated in a magnetic field. Measures of proton density and relaxation curves allow discrimination between different tissue types. Tlweighted images reflect differences in the rate of tissue magnetization and T2-weighted images reflect differences in the rate of signal decay between different tissue types. Early cerebral infarcts (within hours ofonset) appear as low signal regions on Tl-weighted images and as regions of increased signal with T2-weighting. NMR detects areas of infarction, including small lacunar lesions, earlier and with greater sensitivity than CT scanning,6669 and may be especially helpful in the posterior fossa where conventional CT scans are often degraded by bony artifact. 70 give a qualitative picture of cerebral bloodflow in the infarct area. Changes in response to vasodilators such as acetazolamide assess the integrity of cerebral autoregulation and may give some idea of tissue viability.74 SPECT studies may be more sensitive than CT scanning in the detection of early cerebral infarction but cannot reliably diagnose haemorrhage or predict prognosis.75'6 '33Xenon contrast CT scans are an alternative method of measuring cerebral blood flow but require the patient to remain immobile for 15-20 minutes whilst the scan is performed, and xenon has soporific effects and may alter flow by acting as a vasodilator. Xenon provides a quantitative measure of cerebral blood flow correlating well with other methods.77 (D) Positron emission tomography (PET)
Certain radio-isotopes decay spontaneously, emitting a small positively charged particle (positron), which interacts with an electron, producing gamma radiation which is detectable with a gamma camera. This technique enables precise and quantitative analysis of radioisotope concentrations from molecules such as "IC, 13N, 150 and '8F which may be attached to normal metabolic substances such as oxygen, glucose and water. Unfortunately, these radio-isotopes can only be produced using a cyclotron and have short half-lives (between a few minutes and two hours) which restricts their use to a few centres in the world. Quantitative regional measurements can be made of cerebral blood flow, blood volume, oxygen uptake and glucose metabolism enabling definition of normal brain from infarct, and the region of ischaemic but potentially viable brain surrounding the infarct (the 'ischaemic penumbra').78 Areas of altered metabolism distant to the area of infarction have also been identified which may have an important pathophysiological role (diaschisis). Metabolic abnormalities on PET scanning may predict the development of future structural lesions and act as a guide to appropriate treatment in acute cerebral infarction, although its potential for widespread use is limited because of the enormous costs involved.
Conclusion
Many investigations are now available for the assessment of patients with acute stroke. The investigations which need to be performed in an individual patient will depend on patient characteristics, management priorities and local facilities. A good clinical history and examination is the most cost-effective investigation of all. The basic investigations outlined in the first section are a costeffective addition to the clinical examination and are applicable to virtually all stroke patients. CT scanning may be required in a large proportion of patients, the exact proportion depending largely on whether clinicians plan to use anti-haemostatic agents for either acute treatment or long-term secondary prevention, whereas other investigations such as echocardiography are indicated only in selected patients in whom there is diagnostic uncertainty, or in whom management may be significantly altered. The newer research techniques outlined require further evaluation and may assume great importance in the future when more effective therapies for the acute treatment of stroke are available.
